Merck & Co (MRK)
$126.45
0.60 (0.48%)
MRK Stock Quote Delayed 30 Minutes
Top 10 Dow Dividend Stocks for February
Income investors could do a lot worse than buying into these venerable blue chips -- especially the stock that continues to hold the crown.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
320.09B
PE Ratio
140.50
EPS
0.9
Volume (Avg. Vol.)
6.79M
Day's Range
$124.91 - $126.60
52-Week Range
$99.14 - $134.63
Dividend & Yield
$2.92 (2.31%)
MRK Stock Predictions, Articles, and Merck & Co News
Flu Season: Where Investors Can Find Relief
This year's flu looks particularly troublesome, but that's good new for the many companies that benefit from flu sufferers' ills. Here's a look at some of them.
5 Mutual Funds to Buy for 2013
Simplify at least part of your portfolio by picking some solid mutual funds in the coming year. Here are five promising names to consider.
Which Abbott Is the One to Own Post-Split?
Both offer good prospects, but if you can choose just one, AbbVie -- which is the device and diagnostics side -- looks a tad more promising than the pharma arm.
From the Experts: 4 Stocks to Hold Forever
Forever may be a long time, but these stocks picked by our InvestorPlace experts are tried-and-true investments that you can count on for the long haul.
Top 10 Dow Dividend Stocks for December
Income investors could do a lot worse than buying into these venerable blue chips, but some only have great yields thanks to a not-so-hot year.
Big Pharma: 2012-13’s Flu Vaccine Field
Here's a look at the various big pharma stocks that could see a bump from an early start to this year's flu season.
Effective Alzheimer’s Drugs May Be Just Three Years Away
New research, both by scientists and the big drug companies, is leading to increased hope for sufferers of Alzheimer's disease.
27 Companies Increasing Dividends
Disney, PepsiCo and Seagate Technology are among companies making this week's list of dividend-increasing stocks.
Here’s What President Obama’s Win Means For Your Money
President Obama's reelection opens up the possibilities for investors looking at "glocal" opportunities and in the energy sector.
China’s Diabetes Epidemic Boosts Big Pharma
The world's largest population of diabetics is growing alarmingly, and combating it raises the prospects for names like Merck, Novo Nordisk and Sanofi.
Is the Election About Lost Dreams Or New Promises?
The election is finally upon us, and by Wednesday lots of questions will be answered, but big problems remain for the winner to try and figure out in the future
Novartis Flu Vaccine Ban: Who Wins?
Two of Novartis' flu vaccines have been banned in seven countries, but the market's reaction to the move may be a bit overdone. Here's why.
Look Who’s Asking Congress for Deficit Action
It would be a little easier to abide the Campaign to Fix the Debt CEO Fiscal Leadership Council's effort -- if the execs on it weren't so hypocritical.
Top 10 Dow Dividend Stocks for October
Income investors could do a lot worse than buying into these venerable blue chips, but watch out -- one of these plays is looking pretty risky.
Should I Buy Abbott Labs? 3 Pros, 3 Cons
Success in a drug regimen meant to treat hepatitis C is buoying shares of Abbott Laboratories, but has the easy money in ABT shares already been made?
5 Ways to Invest $10,000 Now
Getting started isn't nearly as tough as you may think. And remember: Not all investments have to be in the capital markets.
6 Pharmaceutical Stocks to Buy Now
The grades of six Pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
7 Pharmaceutical Stocks to Buy Now
The grades of seven Pharmaceutical stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.
A Healthy Portfolio Is Heavy in Health Care
Investors would be foolish to ignore the massive demographic shift and growth potential that is boosting health care stocks right now.
Should I Buy Energizer? 3 Pros, 3 Cons
Energizer just announced an aggressive cost-cutting program; will it be enough to get the stock back on track? Get the verdict on ENR.
